I'll let my kids know. Thank you.
In relation to animate biotechnology, which is actually discussed at section 2.14 of the May 2016 discussion paper, is it the case that the federal government previously considered a stand-alone regime for the assessment of the risks related to animate biotechnology, and if that's the case, could the departments involved please provide the written materials on what was previously considered? I know we can do an access to information request, but I'd rather not go through that process.